The Israeli governments research institute on April 4 said it has successfully isolated a key antibody to the CCP virus, also known as the the novel coronavirus, potentially providing a possible treatment for the current pandemic.
In a joint statement with the Israel Institute for Biological Research (IIBR) published Monday night, the countrys defense minister, Naftali Bennet, said the agency briefed him on its “significant breakthrough” when he visited the facilities on Monday, explaining that they had effectively isolated the antibody that attacks the virus monocularly and neutralizes COVID-19, the disease caused by the CCP virus, in carriers bodies.
The statement quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which they will seek out international manufacturers to mass-produce it.
According to What Is Biotechnology?, monoclonal antibodies are “laboratory produced antibodies designed to recognise and bind to specific receptors found on the surface of cells.” The website states they are “derived from natural antibodies, complex proteins derived from a single B cell made by the bodys immunological defence system to recognise and fight foreign invaders such as bacteria and viruses.”
So far, facilities researching antibodies have developed treatments from antibodies that are polyclonal, or derived from two or more cells of different ancestry, Reuters reported.
On Twitter, Israels Ministry of Defense said the antibody has three key parameters: It is monoclonal, new and refined, and contains an exceptionally low proportion of harmful proteins, it is able to neutralize the CCP virus and it was specifically tested on it.
In the past two days, the Israel Institute for Biological Research (IIBR), has completed a groundbreaking scientific development, determining an antibody that neutralizes the corona virus (SARS-COV-2) 1/3
— Ministry of Defense (@Israel_MOD) May 5, 2020
“Based on comprehensive Read More – Source